Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
2017 Nobel Chemistry Prize Awarded for Developments in Cryo-electron Microscopy
Posted on October 4th, 2017 by Betsy Davis in Chemistry
One of the year’s most exciting moments for the global chemistry community is here today, as The Royal Swedish Academy of Sciences has made its choice for the Nobel Prize in Chemistry 2017. The prize has been awarded to Jacques Dubochet (University of Lausanne, Switzerland), Joachim Frank (Columbia University, USA) and Richard Henderson (MRC Laboratory of Molecular Biology, UK) for developing cryo-electron microscopy for the high-resolution structure determination of biomolecules in solution.
Through their work over the last few decades, these three scientists have revolutionized biochemistry by making it possible to clearly see images of biomolecules mid-movement. This microscopic technology is a major achievement because researchers are now able to visualize protein structures and molecular processes that were previously invisible, allowing them to better understand the chemistry of life.
The technique is still in development, so most of its potential—which includes the development of pharmaceuticals—is yet to be seen. However, the New York Times reports that it is already powering some advances as “Last year, scientists were able to use cryo-electron microscopy to analyze the structure of the Zika virus … the same technique was used to figure out the structure of proteins involved with circadian rhythms.”
To learn more about this year’s winners of the Nobel Prize for Chemistry and about cryo-electron microscopy, click here.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Senior Strategic Marketing Manager
- What Were the Biggest Advances in Life Sciences in 2020?
- Pharma Industry Conferences Have Gone Online – Will They Stay There?
- International Life Science Awards Recognize Reaxys
- Five drug development strategies to combat 2019 novel coronavirus
- Unlocking the potential of the Reaxys PhD prize – insights from 4 winners and finalists